Short Interest in Biotricity, Inc. (NASDAQ:BTCY) Increases By 5.9%

Biotricity, Inc. (NASDAQ:BTCY) was the recipient of a large growth in short interest during the month of July. As of July 31st, there was short interest totalling 487,100 shares, a growth of 5.9% from the July 15th total of 460,000 shares. Based on an average daily trading volume, of 81,400 shares, the short-interest ratio is presently 6.0 days. Approximately 17.0% of the shares of the company are short sold.

Biotricity Stock Performance

NASDAQ BTCY traded up $0.01 during trading on Tuesday, hitting $0.41. 38,224 shares of the company’s stock traded hands, compared to its average volume of 81,869. The stock has a market capitalization of $8.87 million, a price-to-earnings ratio of -0.31 and a beta of 1.39. The business has a 50 day moving average of $0.75 and a 200-day moving average of $1.03. Biotricity has a 12-month low of $0.37 and a 12-month high of $2.43.

Biotricity (NASDAQ:BTCY) last announced its quarterly earnings results on Thursday, June 27th. The company reported ($0.47) EPS for the quarter, missing analysts’ consensus estimates of ($0.36) by ($0.11). The company had revenue of $3.18 million for the quarter, compared to the consensus estimate of $3.20 million. On average, analysts expect that Biotricity will post -0.43 EPS for the current year.

Hedge Funds Weigh In On Biotricity

A hedge fund recently bought a new stake in Biotricity stock. AE Wealth Management LLC acquired a new position in shares of Biotricity, Inc. (NASDAQ:BTCY) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 97,751 shares of the company’s stock, valued at approximately $88,000. AE Wealth Management LLC owned approximately 0.45% of Biotricity as of its most recent filing with the Securities and Exchange Commission. 3.89% of the stock is currently owned by institutional investors and hedge funds.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.